{"database": "lobbying", "table": "lobbying_activities", "rows": [[2388538, "8fd9b8d8-bbfd-4866-bc3f-f0b970874a89", "Q4", "HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC", 17966, "EMERGENT BIOSOLUTIONS", 2019, "fourth_quarter", "DIS", "H.R. 2740 - Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2020 - Division A - Title II - Department of Health and Human Services- funding for development, acquisition and stockpiling of medical countermeasures (MCMs) for the U.S. Government, including Public Health Emergency MCMs Enterprise (PHEMCE) and funding to combat the opioid crisis, included as Division A, H.R. 1865 - Further Consolidated Appropriations Act, 2020;\nP.L. 114 - First Responder Anthrax Preparedness Act - implementation of law;\nInitiatives and products to combat the opioid health crisis.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2020-01-17T12:41:46.127000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2388538"], "units": {}, "query_ms": 0.42101391591131687, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}